HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Karo Bio AB (publ) (STO:KARO) carries out the planned second phase of its efficiency program and reduces the number of employees by 10 to 44. The goal is for Karo Bio to become a company that is self-financed and has a commercially attractive and broad development pipeline.
